Sarepta Therapeutics, Inc. (SRPT)

16.30 +0.43 (+2.71%) USD  |  NASDAQ  |  Mar 04, 13:06
More

Sarepta Therapeutics Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
REGENXBIO, Inc. Upgrade
Keros Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade